Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lilach Joseph"'
Autor:
Alona Zer, Oded Icht, Lilach Joseph, Dana Avram, Oded Jacobi, Eyal Fenig, Noga Kurman, Idit Peretz, Sivan Shamai, Ofer Merimsky, Eitan Ben-Ami, Roni Shapira, Anna Ewa Schwarzbach, Hanna Bernstine, Rony Weitzen, Olga Vornicova, Gil Bar-Sela, Salomon M. Stemmer, Michal Lotem
Publikováno v:
Journal of Clinical Oncology. 38:11518-11518
11518 Background: CKS is a mesenchymal neoplasm associated with HHV8 infection. Though recombinant INFa is approved for treatment of AIDS-related KS, data is limited regarding the role of immune modulation in CKS therapy. Based on favorable responses
Autor:
Elizabeth Dudnik, Erez Batat, Oded Icht, Alona Zer, Hammerman Ariel, Pia Raanani, Daniel A. Goldstein, Uri Rozovski, Lilach Joseph, Avi Leader, Galia Spectre, Tzippy Shochat, Baruch Brenner
Publikováno v:
Blood. 134:3654-3654
Introduction It is well established that patients with advanced non-small cell lung cancer (NSCLC) have an increased risk of venous thromboembolism (VTE). VTE risk in cancer outpatients can be stratified using risk scores such as the Khorana score. R
Autor:
Lilach Joseph, Ariel Hammerman, Alona Zer, Daniel A. Goldstein, Erez Battat, Avi Leader, Tzippy Shochat
Publikováno v:
Journal of Clinical Oncology. 37:6608-6608
6608 Background: Advanced NSCLC is associated with an increased risk for VTE, with a reported rate of 8-15%. Clinical observations suggest a higher rate of VTE in patients with ALK-rearranged NSCLC. Clalit Health Services (CHS) is both a healthcare p